Recursion Pharmaceuticals' strategic updates prompted a price target revision by Morgan Stanley on June 26, 2025.
1 report, 0 independent
Updated Jun 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Recursion Pharmaceuticals' strategic updates prompted a price target revision by Morgan Stanley on June 26, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Morgan Stanley
U.S. investment bank
-
Recursion (United States)
company in Salt Lake City, United States
Nothing else this week.
Related events
- Morgan Stanley lowered its target price for Clorox stock on October 25, 2026.
- Morgan Stanley adjusted its price target for CF Industries Holdings.
- Citigroup and Morgan Stanley issued rating and target price updates for Curtiss-Wright.
- Morgan Stanley boosted its target price for Williams-Sonoma, Inc.
- Morgan Stanley, Raymond James Financial, and Keefe, Bruyette & Woods adjusted price targets and ratings for various companies.
Coverage
Newest first; wire copies grouped- Unknown outlet